From those wonderful people who brought you ObamaCare

  • by: |
  • 11/12/2013

From the pages of The Washington Examiner ...

Here comes the next big healthcare disaster, courtesy of HHS

And you thought the rollout of Obamacare was a catastrophe?

Here’s an immediate and critical pending national healthcare disaster — a new flu pandemic with nobody home at the Department of Health and Human Services.

This past April, a new strain of H7N9 avian influenza emerged in China and quickly spread throughout the region.

Though the H7N9 virus was only known to transfer directly from an avian source, numerous people were exposed to the disease’s devastating illnesses.

By the time the virus had momentarily vanished in August, a staggering 44 of the 134 infected had died, a 33 percent mortality rate.

At first, HHS took the necessary steps to address the new pandemic and prepare for the worst. Health and Human Services Secretary Kathleen Sebelius determined that the virus was a threat to U.S. national security and to Americans living abroad.

Subsidiary offices of HHS, the Biomedical Advanced Research and Development Authority and the Centers for Disease and Control, recommended producing a seed vaccine, conducting clinical trials and, if the threat of pandemic remained, contracting manufactures to produce vaccine stockpiles.

Once the virus was identified as a legitimate threat, HHS moved quickly to contract with vaccine manufacturers to produce a vaccine and prepare for mass production if the virus was to resurface, as influenza viruses typically do.

It seemed as though the government was taking on this threat appropriately — until Sebelius’ slogging bureaucracy, those wonderful people who brought you Obamacare, took over.

In September, BARDA contracted three vaccine manufacturers for $110 million to put in order a vaccine and prepare mass vaccine stockpiles once HHS gave them the go-ahead.

Reportedly, HHS was supposed to provide the manufacturers with further instructions by mid-October.

Yet today, HHS still sits on the very production orders that are necessary to stockpile the H7N9 vaccine to protect against a pandemic.

HHS’s timing could not be worse, with flu season already upon us. As of this week, there have been four newly reported cases of the H7N9 virus in China, leading a spokesman for the World Health Organization to conclude succinctly: "Winter is starting."

While experts have stopped short of guaranteeing a spike in H7N9 cases, the threat of a pandemic is anything but far-fetched.

If the second phase of this virus evolves from an avian-transferred virus to a human-to-human transfer, we will see devastating results.

Perhaps staff at HHS should heed the words of their colleague, Dr. Tom Frieden, director of the CDC.

In September, Frieden warned that “nothing has the potential to kill more people than influenza. A strain such as H7N9 could create a pandemic. When something with that much potential to cause widespread harm emerges, we must identify it in hours or days, not weeks or months.”

It will take, at minimum, 60 days to produce the first wave of vaccine stockpiles once an order is given to vaccine manufacturers.

And that is just the first wave, a quantity that would be wholly insufficient for the American public at large. Protecting the entire U.S. population would take many months, time that, frankly, we may not have.

Unfortunately, now HHS has again demonstrated gross incompetence in its obligation to best promote the public health. Its eye is not on the prize of pandemic preparedness.

If the federal bureaucracy continues to stall on producing the H7N9 vaccine, HHS could face a catastrophe that would make the storm seem like a light spring shower.

Peter Pitts, a former FDA associate commissioner, is president of the Center for Medicine in the Public Interest.


Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog